Scottish Brain Sciences

Scottish Brain Sciences is a clinical research organization and health-tech company dedicated to transforming the landscape of neurodegenerative disease research. Founded by world-leading Alzheimer's expert Professor Craig Ritchie, the company focuses on the early detection and prevention of dementia through innovative clinical trial designs. The organization operates a network of brain health centers that integrate cutting-edge research directly into clinical care pathways. A core component of their business is the validation and implementation of blood-based biomarkers and digital tools to identify Alzheimer's pathology in its earliest stages. Through strategic partnerships with major pharmaceutical companies like Roche, Scottish Brain Sciences aims to accelerate the delivery of life-changing treatments to patients. Their unique model leverages Scotland's integrated health data and research infrastructure to provide a rapid, high-quality environment for global neuroscience studies.